Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for quantifying lenacapavir plasma concentrations: Application to therapeutic monitoring

Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus

(2023) Natalie E. Lee et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Strategies to overcome HIV drug resistance-current and future perspectives

(2023) Aura Temereanca et al.   Frontiers in Microbiology

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

(2022) Sorana Segal-Maurer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges

(2022) Vivek Agrahari et al.   Expert Opinion on Drug Delivery

Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial

(2022) Samir K Gupta et al.   Lancet HIV

Lenacapavir: a first-in-class HIV-1 capsid inhibitor

(2021) Hadas Dvory-Sobol et al.   Current Opinion in HIV and AIDS

Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research

(2020) Denise A. Cobb et al.   Expert Opinion on Drug Delivery

Clinical targeting of HIV capsid protein with a long-acting small molecule

(2020) John O. Link et al.   NATURE

Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

(2020) Raphael J Landovitz et al.   Lancet HIV

GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds

(2019) Kamal Singh et al.   Frontiers in Microbiology

Acceptability of a long‐acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076)

(2019) Elizabeth E Tolley et al.   Journal of the International AIDS Society

Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis

(2016) S Teeraananchai et al.   HIV MEDICINE

Antiretroviral Therapy for the Prevention of HIV-1 Transmission

(2016) Myron S. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE